Bupropion 68382-0353
Product NDC
68382-0353- Manufacturer
- Zydus Pharmaceuticals Usa Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- August 2, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA201567
Need to source Bupropion? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bupropion Hydrochloride | 150 mg/1 |
Drug Class
Aminoketone [EPC]Dopamine Uptake Inhibitors [MoA]Increased Dopamine Activity [PE]
Packaging Options(4)
500 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-05)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-06)
1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-10)
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68382-353-16)